Mohamed Hagras - Concepedia

Author

Mohamed Hagras

Al-Azhar University ORCID

Also Known As

Mohamed A. Seleem, Mohamed Hagras

Publications

934

Citations

H-Index

Concepts

All Affiliations

Al-Azhar University Zewail City of Science and Technology Purdue University West Lafayette Ain Shams University Future University in Egypt

About

Mohamed Hagras is an author at Al-Azhar University specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	325
2	Health Sciences	3	3	123
3	Natural Sciences	2	2	45
4	Arts	1	1	16
5	Engineering	1	1	16

Mohamed Hagras

Publications

834

Citations

H-Index

Page 1

	Year	Citations
Medicinal attributes of pyridine scaffold as anticancer targeting agents Esraa A. Mohamed, Nasser S. M. Ismail, Mohamed Hagras, Future Journal of Pharmaceutical Sciences	2021	80
Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation Mohamed Hagras, Moshira A. El Deeb, Heba S. A. Elzahabi, Journal of Enzyme Inhibition and Medicinal Chemistry	2021	70
Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere with bacterial cell wall synthesis Islam Eid, Mohamed M. Elsebaei, Haroon Mohammad, European Journal of Medicinal Chemistry Arylthiazole AntibioticsHealth SciencesAntibioticsMedicineAntibacterial Agent	2017	60
Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant <i>Staphylococcus aureus</i> (MRSA and VRSA) Mohamed Hagras, Haroon Mohammad, Mohamed S. Mandour, Journal of Medicinal Chemistry	2017	49
Synthesis and antibacterial evaluation of a novel library of 2-(thiazol-5-yl)-1,3,4-oxadiazole derivatives against methicillin-resistant Staphylococcus aureus (MRSA) Mohamed H. Hannoun, Mohamed Hagras, Ahmed Kotb, Bioorganic Chemistry Methicillin-resistant Staphylococcus AureusBiochemistryMedicineNovel Library-1,3,4-Oxadiazole Derivatives	2019	49
1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and <i>in silico</i> studies Mohamed Hagras, Marwa A. Saleh, Rogy R. Ezz Eldin, Journal of Enzyme Inhibition and Medicinal Chemistry	2021	44
Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers Heba S. A. Elzahabi, Eman S. Nossier, Rania A. Alasfoury, Journal of Enzyme Inhibition and Medicinal Chemistry	2022	42
Discovery of pyrazolo[3,4-<i>d</i>]pyrimidine and pyrazolo[4,3-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidine derivatives as novel CDK2 inhibitors: synthesis, biological and molecular modeling investigations Ibrahim F. Nassar, Mohammed Taha Abdel Aal, Wael A. El‐Sayed, RSC Advances	2022	40
Synthesis, biological evaluation, and <i>in silico</i> studies of new CDK2 inhibitors based on pyrazolo[3,4- <i>d</i> ]pyrimidine and pyrazolo[4,3- <i>e</i> ][1,2,4]triazolo[1,5- <i>c</i> ]pyrimidine scaffold with apoptotic activity Asmaa A. Mandour, Ibrahim F. Nassar, Mohammed Taha Abdel Aal, Journal of Enzyme Inhibition and Medicinal Chemistry	2022	38
Development of pyrolo[2,3-c]pyrazole, pyrolo[2,3-d]pyrimidine and their bioisosteres as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological evaluation and molecular dynamics investigations Eman M. Azmy, Mohamed Hagras, Menna A. Ewida, Bioorganic Chemistry	2023	38

Page 1